Plus Therapeutics Reports Second Quarter Financial Results and Recent Business Highlights
Plus Therapeutics Reports Second Quarter Financial Results and Recent Business Highlights GlobeNewswire August 14, 2025 Announced CNSide(R) CSF assay platform launch timeline Initiated the REYOBIQ dose optimization trial for patients with leptomeningeal metastases HOUSTON, Aug. 14, 2025 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted […]